The US Food and Drug Administration has approved a corona virus diagnostic test that can be conducted entirely at the point-of-care and can deliver results in 45 minutes.
The test will be able to provide results within hours, rather than days like the existing tests.
Developed by California-based company Cephid, the test would help fast identification of infected people and quickly start treating them and their quarantine.
Point-of-care testing means results are delivered to patients in the patient care settings, like hospitals, urgent care centres and emergency rooms, instead of samples being sent to a laboratory.
Source : All India Radio